News
February 25, 2025

Local healthcare leader joins Regenstrief Institute Board of Directors

Senior Vice President and Chief Clinical Officer for Indiana University (IU) Health, Christopher S. Weaver, M.D., MBA, has joined the Regenstrief Institute Board of Directors.  

A practicing emergency physician, Dr. Weaver brings extensive experience in healthcare leadership and operations. For IU Health, Dr. Weaver oversees quality, pharmacy, supply chain clinical decisions, integrated care management, clinical ethics and the work of chief medical officers across one of the nation’s largest not-for-profit health systems. He also oversees the IU Health Transfer Center, a centralized department that coordinates the transfer of patients between hospitals. 

Before joining IU Health, he served as chief medical officer and chief operating officer at Eskenazi Health, a large public hospital system in Indianapolis with, in addition to its downtown campus, a network of Eskenazi Health Center sites 

Dr. Weaver is a professor of emergency medicine at the Indiana University School of Medicine, where his research spans healthcare administration, emergency procedural sedation and eye emergencies, with a focus on improving medical practices. He has also explored the impact of telemonitoring on reducing hospital readmissions and strategies for enhancing performance measures through quality improvements. 

Regenstrief’s board provides strategic guidance, oversight and management for the internationally respected medical research organization in support of its mission to improve local, national and global healthcare delivery and outcomes united by a vision of pioneering transformative solutions for a healthier world. 

Related News

LOINC version 2.81 release

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release

Regenstrief Institute’s latest LOINC® content update on August 12, introduces two new linguistic variants: Arabic, for users in Jordan,

Regenstrief President and CEO Rachel Patzer, PhD, MPH.

Regenstrief CEO among national honorees for ground-breaking achievements in transplantation

SAN FRANCISCO – Regenstrief Institute President and Chief Executive Officer Rachel Patzer, PhD, MPH, is among a select group

LOINC 2025 Conference - Montreal, Canada

Regenstrief to host 2025 LOINC® conference in Montréal, Canada, Oct. 7-10

First LOINC conference in Canada — home to one of LOINC’s largest user bases  Regenstrief Institute Health Data Standards

Katie Ross-Driscoll, PhD

Regenstrief researcher receives Showalter award to improve access to organ transplants using learning health systems approach

Regenstrief Institute Research Scientist Katie Ross-Driscoll, PhD, MPH, has been awarded a 2025 Ralph W. and Grace M. Showalter